• Home
  • [Japan] Humanized Mice and Patient Derived Xenografts in Individualized Medicine

[Japan] Humanized Mice and Patient Derived Xenografts in Individualized Medicine

  • 16 Mar 2017
  • 8:30 AM (UTC+09:00)
  • 17 Mar 2017
  • 6:00 PM (UTC+09:00)
  • INNOTECH Building 2F, Yokohama, Japan


  • 20,000 JPY
  • 30,000 JPY

March 16-17, 2017 | Japan

The Jackson Laboratory and Human Genome Organization are pleased to offer a course on Humanized Mice and Patient Derived xenografts (PDX) in Individualized Medicine. This two-day event will cover lectures on humanized mice, PDX and PDX applications in industry. Additionally, workshop sessions will be offered on:

- Technical Components of Drug Dosing and Implanting Tumors in Mice

- Immunodeficient Models: Developments and Limitations 

- Lentivirus for Gene Delivery In-vitro and In-vivo

- Humanization of Immuondeficient Mice and Their Use in Immuno Oncology Studies 


Michael Brehm, Ph.D., University of Massachusetts Medical School, USA

Carol Bult, Ph.D., The Jackson Laboratory, USA

Jennifer Corrigan, M.S., The Jackson Laboratory, USA

James Keck, Ph.D., The Jackson Laboratory, USA

Charles Lee, Ph.D., FACMG, The Jackson Laboratory, USA

Henry Li, Ph.D., Crown Bioscience, USA

Renata Stripecke, Ph.D., Hannover Medical School, Germany

Livio Trusolino, M.D., Ph.D., Instituto di Ricovero e Cura a Carattere Scientifico, Italy

Minan Wang, Ph.D., The Jackson Laboratory, USA

Li-Chin Yao, Ph.D.The Jackson Laboratory, USA


Noriko Gotoh, M.D., Ph.D., Cancer Research Institute of Kanazawa University

Fumihiko Ishikawa, M.D, Ph.D., RIKEN Center for Integrative Medical Sciences

Shumpei Ishikawa, M.D., Ph.D., Tokyo Medical and Dental University, Japan

Yohei Miyagi, M.D., Ph.D., Kanagawa Cancer Center Research Institute

© 2016 Human Genome Organisation. All rights reserved.